Cleared Traditional

K120637 - SYNAPSE 3D BRAIN PERFUSION

K120637 is the FDA 510(k) clearance for SYNAPSE 3D BRAIN PERFUSION by Fujifilm Medical System U.S.A., Inc.. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 68-day FDA review.

K120637 · Fujifilm Medical System U.S.A., Inc. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 2012
Decision
68d
Days
Class 2
Risk

K120637 is an FDA 510(k) clearance for the SYNAPSE 3D BRAIN PERFUSION. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Fujifilm Medical System U.S.A., Inc. (Stamford, US). The FDA issued a Cleared decision on May 8, 2012 after a review of 68 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Fujifilm Medical System U.S.A., Inc. devices

Submission Details

510(k) Number K120637 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received March 01, 2012
Decision Date May 08, 2012
Days to Decision 68 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
39d faster than avg
Panel avg: 107d · This submission: 68d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1127
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K120637.
SCENIUM 2.0
K121074 · Siemens Medical Solutions USA, Inc. · Jun 2012
SYNAPSE 3D NODULE ANALYSIS
K120679 · Fujifilm Medical Systems U.S.A, Inc. · Jun 2012
QLAB WITH FHN AND VPQ PLUG-IN
K121223 · Philips Ultrasound, Inc. · May 2012
SURGICASE CONNECT
K113599 · Materialise NV · Apr 2012
3.7 MP COLOR LCD MONITOR, RADIFORCE MX270W
K113240 · Eizo Nanao Corporation · Apr 2012
2MP MONOCHROME LCD MONITOR, RADIFORCE GX240
K120407 · Eizo Nanao Corporation · Apr 2012